Alexander Cashman
Psychiatry · Baton Rouge, LANPI 1912401712
Payments from drug & device makers
Across 109 payments — averaging $21.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Corium, LLC$443
- Teva Pharmaceuticals USA, Inc.$282
- Neurocrine Biosciences, Inc.$275
- AbbVie$272
- Otsuka America Pharmaceutical, Inc.$242
- Lundbeck LLC$169
- plus $657 from 13 others
What the payments were for
- Food & beverage$2,340100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Corium, LLC | 19 | $443 |
| Teva Pharmaceuticals USA, Inc. | 7 | $282 |
| Neurocrine Biosciences, Inc. | 11 | $275 |
| AbbVie | 15 | $272 |
| Otsuka America Pharmaceutical, Inc. | 13 | $242 |
| Lundbeck LLC | 10 | $169 |
| Alkermes, Inc. | 7 | $169 |
| Johnson & Johnson | 4 | $71 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $70 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $69 |
| E.r. Squibb & Sons, L.L.C. | 4 | $64 |
| Ironshore Pharmaceuticals Inc. | 2 | $29 |
| Tris Pharma Inc | 1 | $25 |
| Neos Therapeutics, LP | 1 | $20 |
| Indivior Inc. | 1 | $19 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
| Bioxcel Therapeutics, Inc. | 1 | $17 |
| Luye Pharma (USA) Ltd. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Austedo XR$122
How this compares
$2,340 in reported general payments places this provider in the 75th percentile of 474 psychiatry providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 13 | $1,566 |
| Aripiprazole | 17 | $820 |
| Olanzapine | 24 | $709 |
| Trazodone Hcl | 26 | $599 |
| Lamotrigine | 52 | $541 |
| Quetiapine Fumarate | 28 | $400 |
| Lithium Carbonate | 40 | $342 |
| Buspirone Hcl | 18 | $273 |
| Duloxetine Hcl | 13 | $159 |
| Sertraline Hcl | 16 | $97 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 12 | $78 |
| Escitalopram Oxalate | 19 | $75 |
| Fluoxetine Hcl | 21 | $68 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Baton Rouge
- Larry WarnerBaton Rouge$495K
- Abdul KhanBaton Rouge$156K
- Donna FargasonBaton Rouge$11K
- Aniedi UdofaBaton Rouge$9K
- Sudheera RachamalluBaton Rouge$7K
- Jason BoudreauxBaton Rouge$5K
- Kashinath YadalamLake Charles$3.8M
- Guy BrannonShreveport$1.4M
- Patrick HayesLake Charles$853K
- Maria CruseThibodaux$522K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.